QuidelOrtho Corp at Raymond James Institutional Investors Conference Transcript
Great. Good afternoon, everyone. I'm Andrew Cooper, lead diagnostics analyst here at Raymond James. Pleased to be joined by the entire office of the CEO from QuidelOrtho to this morning. A lot going on, plenty to talk about here. So we're going to do a fireside chat. Like I said, the full team, happy to be joined on the stage by Mike Iskra, Interim CEO, Joe Busky, CFO; and Rob Bujarski, COO and President, I believe, now, right, as well as Juliet Cunningham in the audience who leads the IR efforts. Again, going to be a fireside chat. But maybe, Mike, just to start us off, can you take a few minutes, give some background on the company, the areas you play, the markets you play in, how you're positioned? And then some of what's going on maybe over the past couple of years in terms of COVID and all the moving parts there?
Yes, I can take a moment. I can take the whole
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investorsā 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
